INTRODUCTION AND OBJECTIVES: Electronic-cigarette smoke (ECS) is designed to deliver nicotine via controlled heating of nicotine-containing organic solution. This process involves neither tobacco leaves nor burning. ECS is therefore considered a safe alternative to tobacco smoke (TS), because ECS delivers a TS 'high' without carrying the TS negative effects. However, we found that ECS induces mutagenic DNA adducts in the mouse bladder mucosa. We also found that nicotine not only induces the same DNA adducts, reduces DNA repair capacity but also enhances human urothelial cells' mutational and tumorigenic transformation susceptibility in vitro. We propose that ECS may induce bladder cancer. In this study we tested the ECS bladder tumorigenicity in mice.
METHODS: 1. ECS exposure. Mice were exposed to ECS generated from e-juice [nicotine plus Vehicle (polypropylene glycol and glycerin)], Vehicle or filtered ambient air 4 h/day, 5 d/wk for 52 weeks.
2. Histopathology. Bladders were fixed in buffered Formalin and embedded in paraffin at the end of exposure. Urothelial cross-sections were stained with H&E or antibodies for proliferation markers MCM-2 and PCNA and basal cell marker KRT5.
RESULTS: Although no tumor was detected in the bladders of all the experimental groups, simple urothelial hyperplasia, characterized by significantly increased urothelial layers (5-8 layers), as opposed to 3 layers in normal mice, were evident in mice exposed to ECS. These lesions showed significant expansion of Krt5-positive basal urothelial cells, and marked elevation of cell proliferation markers, MCM2 and PCNA. Nodular hyperplasia was also frequently observed, with fibrovascular cores and branching proliferative urothelial structures. Overall, 18 of 30 (60%) ECS-exposed mice, 1 of 16 (6.3%) vehicleexposed mice and 0 of 17 (0%) filtered air-exposed mice developed urothelial hyperplasia (p<0.001).
CONCLUSIONS: ECS induces urothelial hyperplasia in mice.
INTRODUCTION AND OBJECTIVES:
To assess the diagnostic accuracy and therapeutic efficacy of probe-based confocal laser endomicroscopy (pCLE), which provides real-time, in vivo histological information during transurethral resection of bladder tumors.
METHODS: We performed a prospective study between August 2013 and August 2014. pCLE was carried out on a total of 119 lesions in 75 patients. We analyzed the diagnostic accuracy of pCLE by comparing the confocal image reports with the pathology reports of surgical specimen. Confocal images were interpreted by a single urologist blinded to the pathology reports. The therapeutic efficacy was analyzed by comparing the outcomes in pCLE and non-pCLE groups.
RESULTS: In a total of 119 lesions, 23 were benign and 96 were malignant. The detection accuracy for malignant lesions with pCLE was determined with a sensitivity and a positive predictive value (PPV) of 91.7% and 93.6%, respectively. For high-grade versus lowgrade bladder cancer, sensitivity and PPV of pCLE were 94.5% and 89.7%, respectively. Distinguishing carcinoma in situ (CIS) from inflammatory lesions was also accurate with sensitivity, specificity, and PPV of 71.4%, 81.3%, and 83.3%, respectively. The KaplanMeier curves revealed that the recurrence-free survival rate was significantly higher in the pCLE group than in the non-pCLE group (p[0.031).
CONCLUSIONS: Probe-based confocal laser endomicroscopy is a promising method to provide the surgeon during the transurethral resection of a bladder tumor with real-time tumor histology, regardless of the tumor's gross appearance. Furthermore, it may also improve the therapeutic efficacy with longer recurrence-free periods.
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MP63-04 QUANTITATIVE NUCLEAR FEATURES OF HEMATOXYLIN-EOSIN SPECIMENS FROM INITIAL TRANSURETHRAL RESECTION FOR PREDICTING NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE
Naoto Tokuyama*, Akira Saito, Yosuke Hirasawa, Takeshi Hashimoto, Naoya Satake, Noriko Watanabe, Tatsuo Gondo, Yoshihiro Nakagami, Kazunori Namiki, Masahiko Kuroda, Yoshio Ohno, Tokyo, Japan INTRODUCTION AND OBJECTIVES: In non-muscle invasive bladder cancer (NMIBC), clinical management is often based on risk classification with limited subjective tools. Recent development in artificial intelligence and digital pathology has promoted the use of this technology in cancer diagnosis. Analysis of digitalized hematoxylin-eosin (HE) tissue section images contributes to quantitative evaluation of cancer lesion morphology. We aimed to develop a novel prediction model for intravesical recurrence based on computer measured nuclear morphological features in NMIBC cases. METHODS: We investigated 30 patients diagnosed with NMIBC. A pathologist annotated digitalized HE tissue slides for bladder cancer. Nuclei were segmented from the annotated region of interest (ROI). Following image processing techniques, we assessed 992 nuclear morphological features from each nucleus e.g., nucleus size, roundness, contour length, intra-nucleus texture data. To identify specific features useful for intravesical recurrence prediction, a multiclass stepwise discriminant analysis was done. We performed canonical discriminant analysis to obtain recurrence probability for each patient. We also applied support vector machine (SVM) to 24 cases; we validated the prediction model by testing 6 cases.
RESULTS: From the digitalized HE tissue slide images, 317 ROIs were annotated. We examined 347,744 nuclei. Based on stepwise discriminant analysis, we selected 49 specific features. Canonical discriminant analysis showed a predictive accuracy of 100%. Table 1 shows results of the SVM model that used 64 images obtained from 6 patients; the accuracy, sensitivity, and specificity were 84%, 91%, and 73%, respectively. The predictive model showed that 8 and 3 images were false positive and false negative, respectively. CONCLUSIONS: Our results suggest that a novel prediction model can be created by SVM learning of computer extracted nuclear morphological features in NMIBC cases.
